Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Schistosoma japonicum | ko:K04588 secretin receptor, putative | Get druggable targets OG5_139196 | All targets in OG5_139196 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Kinase, PLK | 0.0389 | 1 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0389 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0207 | 0.4667 | 0.438 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.0775 | 0.0277 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0389 | 1 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.2815 | 0.2427 |
Schistosoma mansoni | kinase | 0.0198 | 0.4388 | 0.4085 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0075 | 0.0775 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0389 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0075 | 0.0775 | 0.0775 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0066 | 0.0512 | 0.0512 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.2815 | 0.2815 |
Echinococcus granulosus | tar DNA binding protein | 0.0316 | 0.7867 | 0.7752 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0389 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0075 | 0.0775 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0389 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0389 | 1 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0389 | 1 | 0.5 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0389 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0389 | 1 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.2815 | 0.2427 |
Loa Loa (eye worm) | hypothetical protein | 0.0207 | 0.4667 | 0.438 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0389 | 1 | 1 |
Brugia malayi | RNA binding protein | 0.0316 | 0.7867 | 0.7867 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0066 | 0.0512 | 0.0512 |
Schistosoma mansoni | tar DNA-binding protein | 0.0316 | 0.7867 | 0.7752 |
Loa Loa (eye worm) | TAR-binding protein | 0.0316 | 0.7867 | 0.7752 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0389 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0389 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0142 | 0.2744 | 0.2744 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0207 | 0.4667 | 0.4667 |
Schistosoma mansoni | tar DNA-binding protein | 0.0316 | 0.7867 | 0.7752 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0316 | 0.7867 | 0.7752 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0389 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0316 | 0.7867 | 0.7752 |
Schistosoma mansoni | tar DNA-binding protein | 0.0316 | 0.7867 | 0.7752 |
Schistosoma mansoni | hypothetical protein | 0.0142 | 0.2744 | 0.2353 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0075 | 0.0775 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0316 | 0.7867 | 0.7752 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0389 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0316 | 0.7867 | 0.7867 |
Trypanosoma brucei | polo-like protein kinase | 0.0389 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0142 | 0.2744 | 0.2353 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0389 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0316 | 0.7867 | 0.7752 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0389 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0075 | 0.0775 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0316 | 0.7867 | 0.7752 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0316 | 0.7867 | 0.7867 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0207 | 0.4667 | 0.4667 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.